Clinical Trials Browser

Phase 2 × Adrenal Gland Neoplasms × Gefitinib × Clear all

NCT00215202 2018-05-17

Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)

Phase 2 Completed

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms